TherapeuticsMD, Inc.
(NASDAQ : TXMD)

( )
TXMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.27%139.042.8%$495.45m
ZTSZoetis, Inc. Class A
2.26%95.371.9%$232.38m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
4.05%17.982.1%$138.85m
KINKindred Biosciences, Inc.
3.44%10.830.3%$2.34m
PETXAratana Therapeutics, Inc.
2.55%4.428.5%$2.03m
JAGXJaguar Animal Health, Inc.
-0.42%0.249.8%$0.06m
CPHIChina Pharma Holdings, Inc.
-3.05%0.270.1%$0.05m

Company Profile

TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 2008 and is headquartered in Boca Raton, FL.